Financials

  • Market Capitalization 2.55 B
  • Employee 370
  • Founded 2016
  • CEO N/A
  • Website www.tarsusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RB9BNQ7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-51.5
Relación precio/flujo de caja
7.58

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1827
IMNM
Immunome, Inc. - Common Stock
22.80 USD-2.36%-5.00%+22.38%+166.36%2.58 B USD
1829
KOD
Kodiak Sciences Inc - Common Stock
41.10 USD-0.51%+9.34%+17.80%+675.47%2.57 B USD
1845
BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
9.91 USD-5.17%-4.16%+13.13%+10.11%2.52 B USD
1865
VCEL
Vericel Corporation - Common Stock
47.49 USD+1.04%+0.87%+25.40%+30.65%2.43 B USD

Noticias